Another Case of Rituxan Induced PML
On October 23, 2009 the U.S. Food & Drug Administration (FDA) issued an urgent warning to patients and physicians regarding Rituxan. The FDA and the drugs manufacturer have learned of a third case of Rituxan induced progressive multifocal leukoencephalopathy (PML).
Provided below are links to the FDA and manufacturers website(s). To learn more about Rituxan induced PML, please also visit our firms main Rituxan page by clicking the following link: Rituxan Lawsuit
Additional Resources:
- FDA: Rituxan (rituximab) – PML
- Genentech, Inc. and Biogen Idec, Inc: IMPORTANT DRUG WARNING Regarding RITUXAN® (Rituximab)
Do I Have a Rituxan Lawsuit?
The Defective Drugs & Products Liability Litigation Group at our law firm is an experienced team of trial lawyers that focus exclusively on the representation of plaintiffs in Rituxan lawsuits. We are pursuing individual litigation nationwide and currently accepting new Rituxan induced Progressive Multifocal Leukoencephalopathy, PML and/or brain infection cases in all 50 states.
If you or a loved one have developed a brain infection after being treated with Rituxan, you should contact us immediately. You may be entitled to compensation for your injuries and we can help.
To contact us for a free review of your potential case, please fill out the form below or call us toll free 24 hrs/day by dialing: (866) 588-0600.
